查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1965812

氯仿市场－全球产业规模、份额、趋势、机会、预测：按等级、最终用户、地区和竞争格局划分，2021-2031年

Chloroform Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Grade, By End User, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球氯仿市场预计将从 2025 年的 1,048,620 吨成长到 2031 年的 1,235,420 吨，复合年增长率为 2.77%。

氯仿（化学名称：三氯甲烷）是一种高挥发性、高密度、无色的液态有机化合物，主要用作溶剂，也是生产含氟聚合物和冷媒的重要前驱物。市场成长主要受工业界对聚四氟乙烯（PTFE）等含氟聚合物的强劲需求驱动，这些聚合物是电子和汽车行业高性能应用的关键材料。此外，氯仿作为生产氟烃塑胶-22（HCFC-22）的原料，尤其是在非排放原料应用领域，其持续需求也维持了氯仿的生产水准。

市场概览
预测期 2027-2031
市场规模：2025年 1,048,620吨
市场规模：2031年 1,235,420吨
复合年增长率：2026-2031年 2.77%
成长最快的细分市场 技术级
最大的市场 亚太地区

根据欧洲氯气协会（EuroChlor）预测，到2024年，其成员公司的氯气总产量将达到804.1万吨，为包括氯仿在内的氯甲烷价值链提供关键原料。儘管上游供应稳定，但由于严格的环境法规以及人们对化学品潜在致癌性和毒性的健康担忧，市场面临巨大的障碍。这些监管限制，加上《蒙特娄议定书的逐步淘汰消耗臭氧层物质的全球义务，构成了可能限制未来市场成长的重大挑战。

市场驱动因素

全球氯仿市场的主要驱动力是含氟聚合物（尤其是聚四氟乙烯 (PTFE)）需求的不断增长。 PTFE 的生产高度依赖氯仿作为其主要原料。氯仿具有优异的热稳定性和耐化学性，可加工成氢氟烃塑胶-22 (HCFC-22)，这是合成高性能含氟聚合物的关键单体，广泛应用于建筑、电子和汽车产业。此外，转向使用全球暖化潜值 (GWP) 更低的冷媒以及采用以氯仿衍生物为关键中间体的特种冷媒混合物也进一步推动了这一需求。凯莫尔公司于 2025 年 2 月发布的「2024 年第四季及全年业绩报告」也印证了这一成长趋势。该报告显示，其热感及特种解决方案部门 2024 年第四季的销售量成长了 7%，主要得益于市场对高性能解决方案和冷媒混合物的强劲需求。

製药製造业的成长也发挥着重要作用，氯仿被用作提取和纯化维生素、生物碱和抗生素的高效溶剂。尤其是在中国和印度等新兴市场，随着製药产量的增加以满足全球医疗需求，高纯度溶剂的使用量也不断增加。根据印度品牌股权基金会 (IBEF) 于 2024 年 7 月发布的《印度製药业分析》，2024 年 6 月印度製药市场成长了 8.8%，凸显了需要溶剂投入的工业活动的成长。这一成长动能也反映在整个氯碱产业，奥林公司 (Olin Corporation) 在 2025 年发布的报告显示，其氯碱产品和乙烯基部门的销售额在 2024 年第四季度环比增长了 9%，表明包括氯仿在内的氯衍生物的工业需求正在復苏。

市场挑战

全球氯仿市场的主要障碍在于其环境安全和毒性方面的严格法规结构。氯仿被列为疑似致癌性，导致各国制定了严格的暴露限值；同时， 《蒙特娄议定书》下的国际义务也在积极推动臭氧消耗物质的逐步淘汰。这些监管压力直接限制了市场，例如对氯仿的关键原料氢氟烃塑胶-22 (HCFC-22) 实施生产配额。因此，製造商被迫在允许应用范围缩小和合规成本增加的环境下运营，这系统性地抑制了生产扩充性，并阻碍了对扩大产能的投资。

近期工业生产数据从数量上印证了这种限制性的商业环境。根据美国化学工业协会（ACC）预测，2024年美国基础化学品产量将下降1.5%。这项降幅凸显了监管挑战对整个氯碱及中间体产业造成的实质影响。由于生产商需要应对累积的环境义务，该行业正面临被迫放缓的生产，儘管上游原材料供应稳定，但氯仿价值链的成长势头却因此停滞不前。

市场趋势

全球产能正在发生结构性转移，并向亚太地区集中，尤其是印度和中国，这两个国家是工业级氯仿的主要出口中心。这项重组的驱动力在于该地区强大的工业基础以及当地氯碱设施为满足全球需求而进行的战略性扩张，这些扩张有效地取代了欧洲和北美的老旧设施。印度氯碱产业业务的成长是这项供应链转移的一个明显征兆。根据古吉拉特邦碱业和化学品有限公司于2024年8月发布的《2023-24年度古吉拉突邦》，该财年总产量达到2,046,173公吨，较去年同期成长12.88%。产量的显着成长印证了亚太地区製造商不断扩大其在全球市场份额的趋势。

同时，受製药和科学研发扩张的推动，氘代氯仿作为核磁共振（NMR）波谱分析中高品质溶剂的应用日益增长。随着药物研发中复杂有机分子的结构分析和品管变得愈发重要，高纯度同位素溶剂的需求也不断扩大。实验室规模化学研究的这一发展势头也体现在领先的生命科学供应商的财务表现中。默克集团（Merck KGaA）于2024年11月发布的2024年第三季财报显示，其生命科学业务年增2.1%至22.1亿欧元，主要得益于科学与实验室解决方案业务的復苏。这项商业性成长凸显了包括氘代氯仿在内的先进分析试剂在支援全球科研基础设施方面日益增长的重要性。

目录

第一章概述

第二章：调查方法

第三章执行摘要

第四章：客户心声

第五章：全球氯仿市场展望

  • 市场规模及预测
    • 按金额
  • 市占率及预测
    • 等级分类（技术级、醇稳定级、氟化级）
    • 依最终用户（建筑、农业、运输、医疗、化学、製造、其他）划分
    • 按地区
    • 按公司（2025 年）
  • 市场地图

第六章：北美氯仿市场展望

  • 市场规模及预测
  • 市占率及预测
  • 北美洲：国别分析
    • 我们
    • 加拿大
    • 墨西哥

第七章：欧洲氯仿市场展望

  • 市场规模及预测
  • 市占率及预测
  • 欧洲：国别分析
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙

第八章：亚太地区氯仿市场展望

  • 市场规模及预测
  • 市占率及预测
  • 亚太地区：国别分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第九章：中东和非洲氯仿市场展望

  • 市场规模及预测
  • 市占率及预测
  • 中东与非洲：国别分析
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非

第十章：南美洲氯仿市场展望

  • 市场规模及预测
  • 市占率及预测
  • 南美洲：国别分析
    • 巴西
    • 哥伦比亚
    • 阿根廷

第十一章 市场动态

  • 促进因素
  • 任务

第十二章 市场趋势与发展

  • 併购
  • 产品发布
  • 近期趋势

第十三章：全球氯仿市场：SWOT分析

第十四章：波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的议价能力
  • 顾客权力
  • 替代品的威胁

第十五章 竞争格局

  • Medical Isotopes, Inc.
  • MP Biomedicals, LLC
  • Oxford Lab Fine Chem LLP
  • Alpha Chemika
  • Arihant Chemical
  • Solvay SA
  • Tokuyama Corporation
  • Shin-Etsu Chemical Co., Ltd.
  • Occidental Petroleum Corporation
  • Merck KGaA

第十六章 策略建议

第十七章：关于研究公司及免责声明

简介目录
Product Code: 25415

The Global Chloroform Market is projected to expand from 1,048.62 Thousand Tonnes in 2025 to 1,235.42 Thousand Tonnes by 2031, reflecting a Compound Annual Growth Rate (CAGR) of 2.77%. Chloroform, chemically known as trichloromethane, is a volatile, dense, and colorless liquid organic compound primarily used as a solvent and a critical precursor in the creation of fluoropolymers and refrigerants. The market's growth is fundamentally anchored by strong industrial demand for fluoropolymers like polytetrafluoroethylene (PTFE), which are vital for high-performance applications within the electronics and automotive sectors. Additionally, the continued necessity for chloroform as a feedstock in producing hydrochlorofluorocarbon-22 (HCFC-22), particularly for non-emissive feedstock purposes, sustains production levels.

Market Overview
Forecast Period2027-2031
Market Size 20251,048.62 Thousand Tonnes
Market Size 20311,235.42 Thousand Tonnes
CAGR 2026-20312.77%
Fastest Growing SegmentTechnical Grade
Largest MarketAsia Pacific

According to Euro Chlor, total chlorine production by its members hit 8,041 kilotonnes in 2024, providing the essential feedstock for the chloromethanes value chain, which includes chloroform. Although upstream supply remains stable, the market faces significant obstacles due to strict environmental regulations and health concerns associated with the chemical's potential carcinogenicity and toxicity. These regulatory constraints, combined with global mandates from the Montreal Protocol aimed at phasing out ozone-depleting substances, pose a considerable challenge that may limit future market growth.

Market Driver

The primary force driving the Global Chloroform Market is the escalating demand for fluoropolymers, especially polytetrafluoroethylene (PTFE), which heavily depends on chloroform as a key feedstock. Chloroform is processed into hydrochlorofluorocarbon-22 (HCFC-22), the essential monomer for synthesizing high-performance fluoropolymers used widely in the construction, electronics, and automotive industries due to their superior thermal stability and chemical resistance. This demand is further boosted by the shift toward refrigerants with lower global warming potential (GWP) and specialized blends that utilize chloroform derivatives as crucial intermediates. This upward trend is evidenced by The Chemours Company's 'Fourth Quarter and Full Year 2024 Results' from February 2025, which noted that the Thermal & Specialized Solutions segment saw a 7% volume increase in the fourth quarter of 2024, largely driven by robust demand for performance solutions and refrigerant blends.

The growth of the pharmaceutical manufacturing sector also plays a significant role, employing chloroform as a highly effective solvent for extracting and purifying vitamins, alkaloids, and antibiotics. As drug production rises to meet global healthcare needs, especially in emerging markets like China and India, the use of high-purity solvent grades has intensified. The India Brand Equity Foundation (IBEF) reported in its 'Indian Pharmaceutical Industry Analysis' from July 2024 that the Indian pharmaceutical market grew by 8.8% in June 2024, highlighting increased industrial activity requiring solvent inputs. This momentum is mirrored in the broader chlor-alkali chain, with Olin Corporation reporting in 2025 that sales in their Chlor Alkali Products and Vinyls segment rose by 9% sequentially in the fourth quarter of 2024, signaling a recovery in industrial demand for chlorine derivatives, including chloroform.

Market Challenge

The major obstacle hindering the Global Chloroform Market is the rigid regulatory framework regarding environmental safety and toxicity. Chloroform's classification as a probable carcinogen has led to strict exposure limits, while international mandates under the Montreal Protocol actively seek to phase out ozone-depleting substances. These regulatory pressures directly restrict the market by imposing quotas on the production of hydrochlorofluorocarbon-22 (HCFC-22), for which chloroform is a vital feedstock. Consequently, manufacturers must navigate a landscape of reduced permissible applications and rising compliance costs, which systematically curbs production scalability and discourages investment in capacity expansion.

This restrictive operating environment is quantitatively demonstrated by recent industrial output data. According to the American Chemistry Council, production volumes for basic chemicals in the United States fell by 1.5% in 2024. This decline illustrates the tangible effect of regulatory challenges on the broader chlor-alkali and intermediates sector. As producers manage these accumulating environmental obligations, the industry experiences a forced slowdown in output, effectively stalling the growth momentum of the chloroform value chain despite the stability of upstream material availability.

Market Trends

Global production capacities are structurally shifting and consolidating in the Asia-Pacific region, particularly in India and China, positioning these nations as the main export hubs for technical-grade chloroform. This realignment is fueled by the region's strong industrial base and the strategic growth of local chlor-alkali facilities to satisfy global demand, effectively replacing older capacity in Western regions. A clear sign of this supply chain transition is the rising operational output in the Indian sector; Gujarat Alkalies and Chemicals Limited's 'Annual Report 2023-24' from August 2024 reported a 12.88% increase in total production volume to 2,046,173 metric tonnes for the fiscal year. This significant rise in output confirms the trend of Asia-Pacific manufacturers securing a larger portion of the global market.

Simultaneously, there is a growing trend toward using deuterated chloroform as a premium solvent in Nuclear Magnetic Resonance (NMR) spectroscopy, driven by increasing pharmaceutical and academic R&D efforts. As structural analysis and quality control of complex organic molecules become critical in drug discovery, the consumption of high-purity isotopic solvents is expanding. This momentum in laboratory-scale chemical research is reflected in the financial results of major life science suppliers; Merck KGaA's 'Quarterly Statement Q3 2024' from November 2024 showed a 2.1% organic sales increase in the Life Science sector to €2,210 million, led by a recovery in Science & Lab Solutions. This commercial growth highlights the rising importance of advanced analytical reagents, including deuterated chloroform, in supporting global research infrastructure.

Key Market Players

  • Medical Isotopes, Inc.
  • MP Biomedicals, LLC
  • Oxford Lab Fine Chem LLP
  • Alpha Chemika
  • Arihant Chemical
  • Solvay S.A.
  • Tokuyama Corporation
  • Shin-Etsu Chemical Co., Ltd.
  • Occidental Petroleum Corporation
  • Merck KGaA

Report Scope

In this report, the Global Chloroform Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Chloroform Market, By Grade

  • Technical Grade
  • Alcohol Stabilized Grade
  • Fluorocarbon Grade

Chloroform Market, By End User

  • Construction
  • Agriculture
  • Transportation
  • Healthcare
  • Chemical
  • Industrial
  • Others

Chloroform Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Chloroform Market.

Available Customizations:

Global Chloroform Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Chloroform Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Grade (Technical Grade, Alcohol Stabilized Grade, Fluorocarbon Grade)
    • 5.2.2. By End User (Construction, Agriculture, Transportation, Healthcare, Chemical, Industrial, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Chloroform Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Grade
    • 6.2.2. By End User
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Chloroform Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Grade
        • 6.3.1.2.2. By End User
    • 6.3.2. Canada Chloroform Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Grade
        • 6.3.2.2.2. By End User
    • 6.3.3. Mexico Chloroform Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Grade
        • 6.3.3.2.2. By End User

7. Europe Chloroform Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Grade
    • 7.2.2. By End User
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Chloroform Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Grade
        • 7.3.1.2.2. By End User
    • 7.3.2. France Chloroform Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Grade
        • 7.3.2.2.2. By End User
    • 7.3.3. United Kingdom Chloroform Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Grade
        • 7.3.3.2.2. By End User
    • 7.3.4. Italy Chloroform Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Grade
        • 7.3.4.2.2. By End User
    • 7.3.5. Spain Chloroform Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Grade
        • 7.3.5.2.2. By End User

8. Asia Pacific Chloroform Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Grade
    • 8.2.2. By End User
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Chloroform Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Grade
        • 8.3.1.2.2. By End User
    • 8.3.2. India Chloroform Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Grade
        • 8.3.2.2.2. By End User
    • 8.3.3. Japan Chloroform Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Grade
        • 8.3.3.2.2. By End User
    • 8.3.4. South Korea Chloroform Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Grade
        • 8.3.4.2.2. By End User
    • 8.3.5. Australia Chloroform Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Grade
        • 8.3.5.2.2. By End User

9. Middle East & Africa Chloroform Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Grade
    • 9.2.2. By End User
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Chloroform Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Grade
        • 9.3.1.2.2. By End User
    • 9.3.2. UAE Chloroform Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Grade
        • 9.3.2.2.2. By End User
    • 9.3.3. South Africa Chloroform Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Grade
        • 9.3.3.2.2. By End User

10. South America Chloroform Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Grade
    • 10.2.2. By End User
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Chloroform Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Grade
        • 10.3.1.2.2. By End User
    • 10.3.2. Colombia Chloroform Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Grade
        • 10.3.2.2.2. By End User
    • 10.3.3. Argentina Chloroform Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Grade
        • 10.3.3.2.2. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Chloroform Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Medical Isotopes, Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. MP Biomedicals, LLC
  • 15.3. Oxford Lab Fine Chem LLP
  • 15.4. Alpha Chemika
  • 15.5. Arihant Chemical
  • 15.6. Solvay S.A.
  • 15.7. Tokuyama Corporation
  • 15.8. Shin-Etsu Chemical Co., Ltd.
  • 15.9. Occidental Petroleum Corporation
  • 15.10. Merck KGaA

16. Strategic Recommendations

17. About Us & Disclaimer